Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Kratom Group Contests FDA's Opioid Finding, Requests Joint Meeting With NIDA

Aug 16 2018

• By Eileen Francis

Related Content

DEA Proposal To Schedule Kratom Stirs Wave Of Opposition

Dec 08 2016

Salmonella In Kratom, Like Use Of The Herb, Exceeds FDA Expectations

Jul 02 2018

FDA's Opioid Label For Kratom Called Misbranding By Marketers

Feb 07 2018

AHPA Backs NDI Filing For Kratom, Experts Question FDA Enforcement

Apr 30 2018

Recalls: FDA Reports Salmonella Contamination In More Kratom Supplements

Jun 25 2018

It's Complicated: FDA Prohibits CBD In Supplements, Enforcement Priority On Disease Claims

Jun 25 2018

Additional Topics

United States Dietary Supplements Enforcement FDA Regulation Safety Consumer

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window